Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

This specific 1-29 sequence is often referred to as the "functional fragment" because it contains the essential binding domain required to activate GHRH receptors in the pituitary gland.

Sermorelin, a synthetic analog of growth hormone–releasing hormone (GHRH 1–29), has long attracted scientific interest due to ...

CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...

Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results ...

New research from scientists at the Marshall University Joan C. Edwards School of Medicine reveals that certain gut microbial byproducts may hold promise as a novel therapy for obesity-associated ...

A mouse study suggests estrogen may increase gut pain by activating specific cells, offering hints to why IBS is more common ...

Lang, T., Ferri, F., Ziegler, F., Di Pizio, A., Behrens, M. (2026). Steroid Hormones Are Potent and Putatively Endogenous Activators of Human Bitter Taste Receptors. Ann N Y Acad Sci.

In recent years, interest has grown around two investigational peptides, BPC-157 and TB-500, proposed as part of a combined research-oriented protocol to explore tissue regeneration, angiogenesis, and ...